business / news / / Benzinga
Harris Teeter is rolling out expanded GLP-1 medication options alongside nutrition support services.
Harris Teeter is expanding GLP-1 medication options with pharmacist and dietitian support services.
KEY POINTS
- Kroger's EPS and revenue estimates have increased, reflecting optimism about new wellness initiatives.
- Kroger is trading at a premium with a P/E of 44.2x, indicating a steep valuation against peers.
- Recent analyst target price upgrades range from $71 to $83, highlighting anticipated upside potential.
- Kroger's performance slightly outpaces its sector despite a 5.69% annual decline in stock price.
COMPANIES
Summarized by Newsio from Benzinga. How we summarize →